drugset / Trial / NCT00190515

A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)

NCT00190515 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the clinical effectiveness of oral UFT/LV comparing 5-FU/l-LV as adjuvant therapy for stage III colorectal cancer.

Timeline

Start
2003-02
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Leucovorin Small molecule 75 mg Intravenous
Subject Leucovorin Small molecule 250 mg/m2 Intravenous
Subject UFT Unknown 300 mg/m2 Oral
Comparator fluorouracil Small molecule 500 mg/m2 Intravenous

Indications